Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

2 Stocks Under $30 to Buy and Hold


What is a reasonable sum of money to start investing in stocks? $10,000? $1,000? $500? The truth is, thanks to online brokers who now offer trades at low or no fees and fractional shares, investors can get their skin in the game at almost any price.

However, for those who prefer acquiring at least one whole share of a company, there are exciting corporations whose stock prices are well below $30. Let's consider two examples: (NASDAQ: EXEL) and Adyen (OTC: ADYE.Y). Here's why these stocks are worth buying and holding onto for a while.

Exelixis is a biotech that focuses on developing cancer drugs. The company owes most of its revenue to just one medicine, Cabometyx, which treats certain forms of liver and kidney cancer. Cabometyx has been a bit of a "pipeline in a drug," constantly grinding out new indications and delivering stronger revenue. Last year, Exelixis' top line increased by 13.6% year over year to $1.8 billion. The company's earnings per share of $0.65 was roughly 16% higher than the previous fiscal year.

Continue reading


Source Fool.com

Exelixis Inc. Aktie

23,90 €
-0,25 %
Die Exelixis Inc. Aktie erleidet heute einen kleinen Rückgang von -0,25 %.
Einseitige Meinung: Exelixis Inc. erhält nur Buy-Einschätzungen und keine Sell-Einschätzungen.
Ein Kursziel von 26 € für Exelixis Inc. impliziert ein leicht positives Wachstum gegenüber dem aktuellen Kurs von 23.9 €.
Like: 0
Teilen

Kommentare